Literature DB >> 2746791

Constant pressure perfusion: a method to determine obstruction in the upper urinary tract.

P W Woodbury1, M E Mitchell, D M Scheidler, M C Adams, R C Rink, A McNulty.   

Abstract

In an effort to define a more physiological method to determine obstruction in the upper urinary tract, the technique of constant pressure perfusion was studied in the canine and porcine models. In contrast to the constant flow technique of Whitaker, constant pressure perfusion is independent of upper tract compliance, uses low fixed pressures (7 to 12 cm. water) in the renal pelvis and measures flow rates from the upper tracts. In the canine and porcine models constant pressure perfusion demonstrated increased sensitivity and better discrimination between normal and partially obstructed systems relative to constant flow. Pressures in nonobstructed canine and porcine renal pelves are normally low (less than 8 cm. water) for flow rates into the bladder of 1 to 5 cc per minute. When using constant pressure perfusion in systems with partial distal ureteral obstruction, low or no flow is appreciated across the obstruction at renal pelvic pressures of 7 to 12 cm. water. By constant flow obstruction is defined in the same systems but only after renal pelvic pressures exceed 15 to 20 cm. water. We believe that there is clear clinical applicability.

Entities:  

Mesh:

Year:  1989        PMID: 2746791     DOI: 10.1016/s0022-5347(17)38840-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  2 in total

1.  Renal and biliary abnormalities in a new murine model of autosomal recessive polycystic kidney disease.

Authors:  J Nauta; Y Ozawa; W E Sweeney; J C Rutledge; E D Avner
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

2.  Quantitative evaluation of upper urinary tract pump function in pigs with acute unilateral lower ureteral obstruction by 640-slice dynamic volume CT.

Authors:  Chongwen Mao; Cong Peng; Song Li; Liling Chen; Mengjing You; Kewei Fang; Shutian Xiang; Yunshan Su
Journal:  BMC Urol       Date:  2021-09-02       Impact factor: 2.264

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.